Vindon storage services

Article

Vindon Scientific provides storage services and equipment to the pharma and biopharma industries from their facilities in the UK, Ireland & USA. Vindon engineers also provide a full Validation and Calibration service for all environmental storage equipment.

Vindon storage services

Vindon’s UK storage suite based in Rochdale offers 2000 cubic meters of GMP compliant controlled environment storage space providing pharmaceutical stability storage at all World Climatic ICH conditions as well as bespoke conditions.

Biological storage at low and ultra-low temperatures is available at temperatures from -20ºC to -80ºC. Vindon’s Ultra-low temperature facility can store millions of samples, vials or tube racks and annual validation and servicing by our in-house engineers ensures the most reliable storage solution.

Vindon’s HTA licensed Cryobank provides cryogenic storage using vapour phase storage systems designed to ensure against sample contamination and provides secure storage for stem cells, cord stem cells, biological samples, DNA and Bone Marrow.

Vindon Scientific also have IMB certified GMP compliant storage facilities in Tramore, Ireland and in the USA with storage suites in Atlanta, Georgia and Los Angeles, California.

Comprehensive backup and security systems at all Vindon facilities protect the integrity of all stored samples.

Vindon engineers offer a full Validation and Calibration service using a combination of UKAS (United Kingdom Accreditation Service) calibrated equipment and state-of-the-art data acquisition systems, Vindon’s qualified and experienced engineers are extensively trained in the validation and calibration of any make/model of environmental chamber as well as our own Vindon manufactured product.

www.vindon.co.uk

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content